Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea3708b29221afdb98dc3b6e22e80490 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2318-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2016-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73d899e68c4a69a6b9d3db7176b6dc28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a5841b1810bd8ce28fb54c9b14979df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a878803b80f55eecfc24a63201228380 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c7b5a00f51dc57c9936d24eda881bbf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66a2e4c5c1dcc958e1153e82241de072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_564aeb475ac55fdbd06dce176715af08 |
publicationDate |
2018-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2018273636-A1 |
titleOfInvention |
Her2 binding proteins based on di-ubiquitin muteins |
abstract |
The present invention relates to new Her2 binding molecules based on di-ubiquitin muteins. The invention further refers to Her2 binding proteins optionally fused or conjugated to a moiety modulating pharmacokinetics or to a therapeutically or diagnostically active component. The invention further relates to the use of these Her2 binding proteins in medicine, preferably for use in the diagnosis or treatment of cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11230576-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11414466-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10584152-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10858405-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10808042-B2 |
priorityDate |
2015-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |